E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
Recruiting
Observational Study
Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 12 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC · Research network
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pathologically confirmed cancer.
* Written informed consent for E²-RADIatE according to applicable legal and ethical requirements
* Planned use of radiotherapy
* Eligibility of the patient confirmed for at least one cohort confirmed
* Patients of 12 years and older
Contacts